CG Oncology Inc. (CGON) vs RadNet, Inc. (RDNT)
A side-by-side comparison of CG Oncology Inc. and RadNet, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CGON
CG Oncology Inc.
$63.67HealthcareDelayed quote: Oct 6, 2026, 3:55 PM EDT
RDNT
RadNet, Inc.
$70.25HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
Total return — CGON vs RDNT
growth of $100 · dividends reinvested · last 3yCGON +84.9% (+22.7%/yr)RDNT +87.1% (+23.2%/yr)RDNT compounded faster over this window
CGON RDNT
CGON vs RDNT: by the numbers
- •CGON is the larger company ($5.62B vs $5.52B market cap).
- •Both run net losses; RDNT's is the smaller (-0.93% vs -3602.68% net margin).
Metrics side by side
Valuation
| Metric | CGON | RDNT |
|---|---|---|
| Forward P/E | N/A | 136.60 |
| P/S ratio | 901.64 | 2.43 |
| P/B ratio | 5.46 | 5.04 |
| EV / EBITDA | N/A | 21.69 |
Profitability
| Metric | CGON | RDNT |
|---|---|---|
| Gross margin | -15.02% | 9.70% |
| Operating margin | -4722.13% | 4.00% |
| Net margin | -3602.68% | -0.93% |
| ROE | -21.80% | -1.93% |
| ROIC | -24.33% | 1.41% |
Growth (annualized)
| Metric | CGON | RDNT |
|---|---|---|
| Revenue CAGR (5Y) | N/A | 12.68% |
| Total return CAGR (5Y) | N/A | 19.72% |
Go deeper
Dig into the metrics
CG Oncology ROERadNet ROECG Oncology operating marginRadNet operating marginCG Oncology revenue growthRadNet revenue growthCG Oncology free cash flowRadNet free cash flow
CG Oncology & RadNet appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.